Financials

People

Activity

Population Health Partners

Company

Investment-firm

Financing round

General

About Company
Population Health Partners is an investment company focused on innovative therapeutics.

Industry

Sector :

Subsector :

Keywords :

IPO status

Private

Description

Population Health Partners is a San Francisco-based venture capital firm that invests in innovative therapeutics.
Similar Companies
252
Kearny Venture Partners

Kearny Venture Partners

Kearny Venture Partners is a healthcare-focused venture capital firm.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Financial Services, Health Care, Venture Capital

Location

San Francisco, CA, USA

count Of Investments

22

count Of Exists

3
Lumira Ventures

Lumira Ventures

Lumira Ventures is a leading North American healthcare and life sciences venture capital firm.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Toronto, ON, Canada

count Of Investments

90

count Of Exists

10
WuXi Healthcare Ventures

WuXi Healthcare Ventures

WuXi Healthcare Ventures is a Chinese investment firm that helps life sciences companies develop transformative therapies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Venture Capital

Location

Cambridge, MA, USA

count Of Investments

24

count Of Exists

4
Versant Ventures

Versant Ventures

Versant Ventures is a healthcare investment firm that helps entrepreneurs build great companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Medical Device, Venture Capital, Health Care

Location

Menlo Park, CA, USA

count Of Investments

290

count Of Exists

61

Financials

Investments
7
Date 
name 
Lead 
type 
Raised 
18.04.2024
Yes
Metsera

Metsera

Metsera operates as a clinical-stage biopharmaceutical company.

Location

New York, NY, USA

total rounds

2

total raised

$290M
Areteia Therapeutics

Areteia Therapeutics

Areteia Therapeutics is developing an oral drug for eosinophilic asthma.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Bernardsville, NJ, USA

total rounds

2

total raised

$425M
Areteia Therapeutics

Areteia Therapeutics

Areteia Therapeutics is developing an oral drug for eosinophilic asthma.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Bernardsville, NJ, USA

total rounds

2

total raised

$425M
Co-Investors

People

Founders
1
Clive Meanwell
Clive Meanwell

Clive Meanwell

Clive A. Meanwell has been a director since 1996. He has served as our chief executive officer since February 2012, our chief executive officer and president from October 2009 to February 2012, as our chief executive officer from August 2004 to October 2009, as our president from August 2004 to December 2004, our executive chairman from September 2001 to August 2004 and as our chief executive officer and president from 1996 to September 2001. From 1995 to 1996, Dr. Meanwell was a partner and managing director at MPM Capital, L.P., a venture capital firm. From 1986 to 1995, Dr. Meanwell held various positions at Hoffmann-La Roche, Inc., a pharmaceutical company, including senior vice president from 1992 to 1995, vice president from 1991 to 1992 and director of product development from 1986 to 1991. Dr. Meanwell received an M.D. and a Ph.D. from the University of Birmingham, United Kingdom.

current job

Population Health Partners
Population Health Partners

Clive Meanwell

Employee Profiles
4
Greg Williams

Greg Williams

Venture Partner

Farah Champsi

Farah Champsi

Partner

Tom Denwood

Tom Denwood

Chief Digital Officer

Clive Meanwell

Clive Meanwell

Executive Chairman

Activity

Recent News
1